Evidence map›Paper›PMID 30055581›Full record

Trial reportBMC infectious diseases2018

Circumcision status at HIV infection is not associated with plasma viral load in men: analysis of specimens from a randomized controlled trial.

Stephanie M Davis, Sherri Pals, Chunfu Yang, Elijah Odoyo-June, Joy Chang, Maroya Spalding Walters, Walter Jaoko, Naomi Bock, Larry Westerman, Carlos Toledo and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00059371 (Trial of Male Circumcision to Reduce HIV Incidence), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00059371 phase3completednot on this map

Trial of Male Circumcision to Reduce HIV Incidence

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2002 to 2006Enrolled2,887ConditionsHIV InfectionsArmsmale circumcision
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stephanie M DavisDivision of Global HIV/AIDS and Tuberculosis, US Centers for Disease Control, Atlanta, GA, USA. smdavis@cdc.gov.ORCID 0000-0003-4878-9701
Sherri PalsDivision of Global HIV/AIDS and Tuberculosis, US Centers for Disease Control, Atlanta, GA, USA.
Chunfu YangDivision of Global HIV/AIDS and Tuberculosis, US Centers for Disease Control, Atlanta, GA, USA.
Elijah Odoyo-JuneDivision of Global HIV/AIDS and Tuberculosis, US Centers for Disease Control, Kisumu, Kenya.
Joy ChangDivision of Global HIV/AIDS and Tuberculosis, US Centers for Disease Control, Atlanta, GA, USA.
Maroya Spalding WaltersDivision of Global HIV/AIDS and Tuberculosis, US Centers for Disease Control, Atlanta, GA, USA.
Walter JaokoDepartment of Medical Microbiology, University of Nairobi, Nairobi, Kenya.
Naomi BockDivision of Global HIV/AIDS and Tuberculosis, US Centers for Disease Control, Atlanta, GA, USA.
Larry WestermanDivision of Global HIV/AIDS and Tuberculosis, US Centers for Disease Control, Atlanta, GA, USA.
Carlos ToledoDivision of Global HIV/AIDS and Tuberculosis, US Centers for Disease Control, Atlanta, GA, USA.
Robert C BaileyDivision of Epidemiology and Biostatistics, University of Illinois Chicago School of Public Health, Chicago, IL, USA.

Funding

Trial of Male Circumcision to Reduce HIV IncidenceU01AI050440 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BAILEY, ROBERT CONVERSE · 2001 to 2009
$14.7M
CIHR HCT 44180National Institute of Allergy and Infectious Diseases AI50440U.S. President's Emergency Plan for AIDS Relief N/A
6 · The paper itself

Abstract

backgroundMale circumcision provides men with approximately 60% protection from acquiring HIV infection via heterosexual sex, and has become a key component of HIV prevention efforts in sub-Saharan Africa. Possible mechanisms for this protection include removal of the inflammatory anaerobic sub-preputial environment and the high concentration of Langerhans cells on the inside of the foreskin, both believed to promote local vulnerability to HIV infection. In people who do acquire HIV, viral load is partially determined by infecting partner viral load, potentially mediated by size of infecting inoculum. By removing a portal for virion entry, prior male circumcision could decrease infecting inoculum and thus viral load in men who become HIV-infected, conferring the known associated benefits of slower progression to disease and decreased infectiousness.

methodsWe performed an as-treated analysis of plasma samples collected under a randomized controlled trial of male circumcision for HIV prevention, comparing men based on their circumcision status at the time of HIV acquisition, to determine whether circumcision is associated with lower viral load. Eligible men were seroconverters who had at least one plasma sample available drawn at least 6 months after infection, reported no potential exposures other than vaginal sex and, for those who were circumcised, were infected more than 6 weeks after circumcision, to eliminate the open wound as a confounder. Initial viral load testing indicated that quality of pre-2007 samples might have been compromised during storage and they were excluded, as were those with undetectable or unquantifiable results. Log viral loads were compared between groups using univariable and multivariable linear regression, adjusting for sample age and sexually transmitted infection diagnosis with 3.5 months of seroconversion, with a random effect for intra-individual clustering for samples from the same man. A per-protocol analysis was also performed.

resultsThere were no viral load differences between men who were circumcised and uncircumcised at the time of HIV infection (means 4.00 and 4.03 log

conclusionCircumcision status at the time of HIV infection does not affect viral load in men.

trial registrationThe original RCT which provided the samples was ClinicalTrials.gov trial NCT00059371 .

Indexed as

Acquired Immunodeficiency SyndromeAdolescentAdultAfrica South of the SaharaCircumcision, MaleHeterosexualityHIVHIV InfectionsHIV SeropositivityHumansKenyaMaleSerologic TestsSexually Transmitted DiseasesSexual PartnersViral LoadCircumcisionClinical trialsHIV preventionInterventionViral load

Identifiers

PMID30055581
PMCPMC6064164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.